Firefly Neuroscience (AIFF) Liabilities and Shareholders Equity (2016 - 2025)
Firefly Neuroscience has reported Liabilities and Shareholders Equity over the past 15 years, most recently at $10.5 million for Q4 2025.
- Quarterly results put Liabilities and Shareholders Equity at $10.5 million for Q4 2025, up 127.71% from a year ago — trailing twelve months through Dec 2025 was $50.2 million (up 195.44% YoY), and the annual figure for FY2025 was $10.5 million, up 127.71%.
- Liabilities and Shareholders Equity for Q4 2025 was $10.5 million at Firefly Neuroscience, down from $12.4 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for AIFF hit a ceiling of $23.4 million in Q4 2021 and a floor of $2.6 million in Q4 2023.
- Median Liabilities and Shareholders Equity over the past 5 years was $7.6 million (2022), compared with a mean of $9.9 million.
- Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 519.09% in 2021 and later plummeted 69.02% in 2023.
- Firefly Neuroscience's Liabilities and Shareholders Equity stood at $23.4 million in 2021, then crashed by 65.84% to $8.0 million in 2022, then plummeted by 66.91% to $2.6 million in 2023, then skyrocketed by 74.21% to $4.6 million in 2024, then skyrocketed by 127.71% to $10.5 million in 2025.
- The last three reported values for Liabilities and Shareholders Equity were $10.5 million (Q4 2025), $12.4 million (Q3 2025), and $14.9 million (Q2 2025) per Business Quant data.